Mackenzie Financial Corp Boston Scientific Corp Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 703,940 shares of BSX stock, worth $63.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

703,940

Previous 667,195 5.51%

Holding current value

$63.5 Million

Previous $51.4 Million 14.81%

% of portfolio

0.09%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$72.96 - $84.0 $2.68 Million - $3.09 Million	36,745 Added 5.51%	703,940 $59 Million
Q2 2024 Aug 14, 2024	SELL	$67.33 - $77.71 $1.5 Million - $1.73 Million	-22,207 Reduced 3.22%	667,195 $51.4 Million
Q1 2024 May 10, 2024	SELL	$57.6 - $68.62 $1.12 Million - $1.33 Million	-19,431 Reduced 2.74%	689,402 $47.2 Million
Q4 2023 Jan 30, 2024	BUY	$48.64 - $57.81 $13.6 Million - $16.2 Million	279,513 Added 65.11%	708,833 $41 Million
Q3 2023 Oct 25, 2023	BUY	$50.19 - $54.68 $2.95 Million - $3.21 Million	58,735 Added 15.85%	429,320 $22.7 Million
Q2 2023 Aug 03, 2023	SELL	$49.72 - $54.64 $2.52 Million - $2.77 Million	-50,746 Reduced 12.04%	370,585 $20 Million
Q1 2023 Apr 24, 2023	BUY	$45.09 - $50.03 $10.9 Million - $12.1 Million	240,903 Added 133.52%	421,331 $21.1 Million
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $413,283 - $493,307	10,447 Added 6.15%	180,428 $8.35 Million
Q3 2022 Oct 07, 2022	SELL	$36.71 - $109.66 $132,633 - $396,201	-3,613 Reduced 2.08%	169,981 $6.58 Million
Q2 2022 Aug 10, 2022	BUY	$35.24 - $47.1 $2.24 Million - $2.99 Million	63,524 Added 57.71%	173,594 $6.47 Million
Q1 2022 May 13, 2022	BUY	$40.9 - $45.1 $718,122 - $791,865	17,558 Added 18.98%	110,070 $4.88 Million
Q4 2021 Feb 14, 2022	SELL	$38.07 - $44.87 $180,908 - $213,222	-4,752 Reduced 4.89%	92,512 $3.93 Million
Q3 2021 Nov 08, 2021	BUY	$41.23 - $45.88 $1.15 Million - $1.28 Million	27,963 Added 40.35%	97,264 $4.22 Million
Q2 2021 Aug 11, 2021	SELL	$38.58 - $44.24 $810,180 - $929,040	-21,000 Reduced 23.26%	69,301 $2.96 Million
Q1 2021 May 14, 2021	BUY	$35.27 - $39.67 $2.02 Million - $2.27 Million	57,278 Added 173.45%	90,301 $3.49 Million
Q4 2020 Feb 10, 2021	SELL	$33.15 - $41.97 $1.57 Million - $1.99 Million	-47,491 Reduced 58.98%	33,023 $1.19 Million
Q3 2020 Nov 13, 2020	SELL	$34.44 - $42.23 $24.2 Million - $29.7 Million	-703,991 Reduced 89.74%	80,514 $3.08 Million
Q2 2020 Aug 13, 2020	SELL	$30.19 - $39.11 $23.7 Million - $30.7 Million	-785,265 Reduced 50.02%	784,505 $27.5 Million
Q1 2020 May 14, 2020	SELL	$25.83 - $45.71 $3.26 Million - $5.77 Million	-126,176 Reduced 7.44%	1,569,770 $51.2 Million
Q4 2019 Feb 13, 2020	SELL	$37.87 - $45.37 $3.15 Million - $3.78 Million	-83,285 Reduced 4.68%	1,695,946 $76.7 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $634,842 - $684,294	15,749 Added 0.89%	1,779,231 $72.4 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $12.2 Million - $15 Million	349,922 Added 24.75%	1,763,482 $75.8 Million
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $41.2 Million - $51 Million	1,251,310 Added 771.22%	1,413,560 $54.3 Million
Q4 2018 Feb 06, 2019	BUY	$31.73 - $39.04 $4.7 Million - $5.79 Million	148,187 Added 1053.74%	162,250 $5.73 Million
Q3 2018 Nov 15, 2018	BUY	$32.83 - $38.63 $57,846 - $68,066	1,762 Added 14.32%	14,063 $541,000
Q2 2018 Aug 13, 2018	BUY	$26.84 - $34.32 $123,812 - $158,318	4,613 Added 60.0%	12,301 $402,000
Q1 2018 May 14, 2018	BUY	$25.2 - $28.54 $193,737 - $219,415	7,688 New	7,688 $210,000

Others Institutions Holding BSX

# of Institutions

1,541

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Boston Scientific Corp Transaction History